Concepedia

CB2 cannabinoid receptor is a novel target for third-generation selective estrogen receptor modulators bazedoxifene and lasofoxifene

Pritesh Kumar, Zhao-Hui Song

Biochemical and Biophysical Research Communications · 2013 · 20 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Molecular characterization of a peripheral receptor for cannabinoids

Sean Munro, Kerrie L. Thomas, Muna Abu-Shaar · Nature · 1993 · 5.1K citations

, , +14

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Lisa A. Matsuda, Stephen J. Lolait, Michael Brownstein et al. · Nature · 1990 · 5K citations

, , +11

The price of innovation: new estimates of drug development costs

Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski · Journal of Health Economics · 2003 · 4.3K citations · Full text

, , +14

Estimating The Cost Of New Drug Development: Is It Really $802 Million?

Christopher Adams, Van V. Brantner · Health Affairs · 2006 · 910 citations

, , +10

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial

Stuart L. Silverman, Claus Christiansen, Harry K. Genant et al. · Journal of Bone and Mineral Research · 2008 · 505 citations

, , +15